Alyeska Investment Group, L.P. - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 324 filers reported holding ARRAY BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is 1.86 and the average weighting 0.6%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$41,312,000
+1069.0%
891,682
+259.5%
0.53%
+945.1%
Q4 2018$3,534,000
-54.7%
248,000
-51.7%
0.05%
-40.7%
Q3 2018$7,804,000
+21.1%
513,417
+33.7%
0.09%
+48.3%
Q2 2018$6,446,000
+127.7%
384,122
+121.5%
0.06%
+152.2%
Q1 2018$2,831,000173,4380.02%
Other shareholders

There were no reported owners of ARRAY BIOPHARMA INC in Q2 2019.

NameSharesValueWeighting ↓
View complete list of ARRAY BIOPHARMA INC shareholders